MSAC application evidence development

Australian Genomics has spearheaded key genomic applications to the Medical Services Advisory Committee (MSAC), including the first genomic application for childhood syndromes and intellectual disability in 2017, and the expanded reproductive carrier testing application in 2021.

In 2024-25, we will develop evidence to support future MSAC applications for rapid genomic sequencing in infantile epilepsy, fetal exomes, and comprehensive genomic cancer profiling. This work will be conducted in collaboration with Cancer Australia, Children’s Cancer Institute/Zero Childhood Cancer, Omico, the VCCC Alliance, and patient support and advocacy organizations.